{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:51:30Z","timestamp":1761490290837},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s10787-017-0365-9","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T04:40:17Z","timestamp":1496205617000},"page":"665-671","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immune-mediated syndromes following intravenous bisphosphonate therapy"],"prefix":"10.1007","volume":"25","author":[{"given":"Noa","family":"Markovits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronen","family":"Loebstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Bank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"issue":"8","key":"365_CR1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.exphem.2009.04.008","volume":"37","author":"Y Abe","year":"2009","unstructured":"Abe Y, Muto M, Nieda M, Nakagawa Y, Nicol A, Kaneko T, Goto S, Yokokawa K, Suzuki K (2009) Clinical and immunological evaluation of zoledronate-activated V\u03b39\u03b3\u03b4 T-cell-based immunotherapy for patients with multiple myeloma. Exp Hematol 37(8):956\u2013968","journal-title":"Exp Hematol"},{"issue":"1","key":"365_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cellimm.2015.04.008","volume":"296","author":"EJ Adams","year":"2015","unstructured":"Adams EJ, Gu S, Luoma AM (2015) Human gamma delta T cells: evolution and ligand recognition. Cell Immunol 296(1):31\u201340","journal-title":"Cell Immunol"},{"key":"365_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/322179a0","volume":"322","author":"I Bank","year":"1986","unstructured":"Bank I, DePinho RA, Brenner MB, Cassimeris J, Alt FW, Chess L (1986) A functional t3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature 322:179\u2013181","journal-title":"Nature"},{"key":"365_CR4","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.4049\/jimmunol.1102403","volume":"188","author":"A Bendersky","year":"2012","unstructured":"Bendersky A, Marcu-Malina V, Berkun Y, Gerstein M, Nagar M, Goldstein I, Padeh S, Bank I (2012) Cellular interactions of synovial fluid \u03b3\u03b4 t cells in juvenile idiopathic arthritis. J Immunol 188:4349\u20134359","journal-title":"J Immunol"},{"issue":"6","key":"365_CR5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3899\/jrheum.100938","volume":"38","author":"Y Berkun","year":"2011","unstructured":"Berkun Y, Bendersky A, Gerstein M, Goldstein I, Padeh S, Bank I (2011) \u03b3\u03b4T cells in juvenile idiopathic arthritis: higher percentages of synovial V\u03b41+ and V\u03b39+ T cell subsets are associated with milder disease. J Rheumatol 38(6):1123\u20131129","journal-title":"J Rheumatol"},{"key":"365_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/322145a0","volume":"322","author":"MB Brenner","year":"1986","unstructured":"Brenner MB, McLean J, Dialynas DP, Strominger JL, Smith JA, Owen FL, Seidman JG, Ip S, Rosen F, Krangel MS (1986) Identification of a putative second t-cell receptor. Nature 322:145\u2013149","journal-title":"Nature"},{"key":"365_CR7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4049\/jimmunol.174.1.252","volume":"174","author":"L Conti","year":"2005","unstructured":"Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S (2005) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated \u03b3\u03b4 T cells: role of cd86 and inflammatory cytokines. J Immunol 174:252\u2013260","journal-title":"J Immunol"},{"key":"365_CR8","first-page":"10","volume":"10","author":"S Dhar","year":"2010","unstructured":"Dhar S, Chiplunkar SV (2010) Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by V\u03b39V\u03b42 T cells. Cancer Immun 10:10","journal-title":"Cancer Immun"},{"issue":"6","key":"365_CR9","doi-asserted-by":"crossref","first-page":"E556","DOI":"10.1073\/pnas.1412058112","volume":"112","author":"T Dimova","year":"2015","unstructured":"Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, Marchant A, Vermijlen D (2015) Effector V\u03b39V\u03b42 T cells dominate the human fetal \u03b3\u03b4 T-cell repertoire. Proc Natl Acad Sci USA 112(6):E556\u2013E565","journal-title":"Proc Natl Acad Sci USA"},{"key":"365_CR10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1160\/TH13-05-0363","volume":"110","author":"M Franchini","year":"2013","unstructured":"Franchini M, Mannucci PM (2013) Acquired haemophilia a: a 2013 update. Thromb Haemost 110:1114\u20131120","journal-title":"Thromb Haemost"},{"key":"365_CR11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/1078-0432.CCR-08-1507","volume":"15","author":"D Generali","year":"2009","unstructured":"Generali D, Bates G, Berruti A, Brizzi MP, Campo L, Bonardi S, Bersiga A, Allevi G, Milani M, Aguggini S, Dogliotti L, Banham AH, Harris AL, Bottini A, Fox SB (2009) Immunomodulation of foxp3+ regulatory t cells by the aromatase inhibitor letrozole in breast cancer patients. Clin Cancer Res 15:1046\u20131051","journal-title":"Clin Cancer Res"},{"key":"365_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1084\/jem.20021500","volume":"197","author":"HJ Gober","year":"2003","unstructured":"Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De Libero G (2003) Human T cell receptor \u03b3\u03b4 cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 197:163\u2013168","journal-title":"J Exp Med"},{"key":"365_CR13","first-page":"688","volume":"5","author":"S Gu","year":"2015","unstructured":"Gu S, Nawrocka W, Adams EJ (2015) Sensing of pyrophosphate metabolites by V\u03b39V\u03b42 T cells. Front Immunol 5:688","journal-title":"Front Immunol"},{"key":"365_CR14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.18.1.975","volume":"18","author":"AC Hayday","year":"2000","unstructured":"Hayday AC (2000) \u03b3\u03b4 cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 18:975\u20131026","journal-title":"Annu Rev Immunol"},{"key":"365_CR15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fimmu.2014.00632","volume":"5","author":"JV Hidalgo","year":"2014","unstructured":"Hidalgo JV, Bronsert P, Orlowska-Volk M, D\u00edaz LB, Stickeler E, Werner M, Schmitt-Graeff A, Kayser G, Malkovsky M, Fisch P (2014) Histological analysis of \u03b3\u03b4 t lymphocytes infiltrating human triple-negative breast carcinomas. Front Immunol 5:632","journal-title":"Front Immunol"},{"issue":"3","key":"365_CR16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/cmi.2011.50","volume":"9","author":"C Hu","year":"2012","unstructured":"Hu C, Qian L, Miao Y, Huang Q, Miao P, Wang P, Yu Q, Nie H, Zhang J, He D, Xu R, Chen X, Liu B, Zhang D (2012) Antigen-presenting effects of effector memory V\u03b39V\u03b42 T cells in rheumatoid arthritis. Cell Mol Immunol 9(3):245\u2013254","journal-title":"Cell Mol Immunol"},{"key":"365_CR17","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/eji.200838366","volume":"38","author":"M Kistowska","year":"2008","unstructured":"Kistowska M, Rossy E, Sansano S, Gober HJ, Landmann R, Mori L, De Libero G (2008) Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR \u03b3\u03b4 cells. Eur J Immunol 38:2200\u20132209","journal-title":"Eur J Immunol"},{"issue":"8","key":"365_CR18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00262-011-1021-7","volume":"60","author":"H Kobayashi","year":"2011","unstructured":"Kobayashi H, Tanaka Y, Yagi J, Minato N, Tanabe K (2011) Phase I\/II study of adoptive transfer of \u03b3\u03b4 T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma. Cancer Immunol Immunother 60(8):1075\u20131084","journal-title":"Cancer Immunol Immunother"},{"key":"365_CR19","first-page":"170","volume":"46","author":"O Kowal-Bielecka","year":"2001","unstructured":"Kowal-Bielecka O, Mr\u00f3z R, Bernacka K, Kowal E, Sierakowski S (2001) gamma delta-Lymphocytes in the peripheral blood of patients with rheumatoid arthritis\u2014correlation with clinical and laboratory parameters of the disease and with the treatment used. Rocz Akad Med Bialymst 46:170\u2013181","journal-title":"Rocz Akad Med Bialymst"},{"issue":"8","key":"365_CR20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/rheumatology\/31.8.527","volume":"31","author":"C Lunardi","year":"1992","unstructured":"Lunardi C, Marguerie C, Walport MJ, So AK (1992) T gamma delta cells and their subsets in blood and synovial fluid from patients with rheumatoid arthritis. Br J Rheumatol 31(8):527\u2013530","journal-title":"Br J Rheumatol"},{"key":"365_CR21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fimmu.2014.00414","volume":"5","author":"V Marcu-Malina","year":"2014","unstructured":"Marcu-Malina V, Balbir-Gurman A, Dardik R, Braun-Moscovici Y, Segel MJ, Bank I (2014) A novel prothrombotic pathway in systemic sclerosis patients: possible role of bisphosphonate-activated \u03b3\u03b4 T cells. Front Immunol 5:414\u2013419","journal-title":"Front Immunol"},{"issue":"8","key":"365_CR22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00262-007-0279-2","volume":"56","author":"SR Mattarollo","year":"2007","unstructured":"Mattarollo SR, Kenna T, Nieda M, Nicol AJ (2007) Chemotherapy and zoledronate sensitize solid tumour cells to V\u03b39V\u03b42 T cell cytotoxicity. Cancer Immunol Immunother 56(8):1285\u20131297","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"365_CR23","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1172\/JCI80840","volume":"125","author":"NE McCarthy","year":"2015","unstructured":"McCarthy NE, Hedin CR, Sanders TJ, Amon P, Hoti I, Ayada I, Baji V, Giles EM, Wildemann M, Bashir Z, Whelan K, Sanderson I, Lindsay JO, Stagg AJ (2015) Azathioprine therapy selectively ablates human V\u03b42+ T cells in Crohn\u2019s disease. J Clin Invest 125(8):3215\u20133225","journal-title":"J Clin Invest"},{"key":"365_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2006.00479.x","volume":"215","author":"CT Morita","year":"2007","unstructured":"Morita CT, Jin C, Sarikonda G, Wang H (2007) Nonpeptide antigens, presentation mechanisms, and immunological memory of human V\u03b32V\u03b42 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 215:59\u201376","journal-title":"Immunol Rev"},{"issue":"10","key":"365_CR25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3727\/096504010X12671222663638","volume":"18","author":"M Naoe","year":"2010","unstructured":"Naoe M, Ogawa Y, Takeshita K, Morita J, Shichijo T, Fuji K, Fukagai T, Iwamoto S, Terao S (2010) Zoledronate stimulates \u03b3\u03b4 T cells in prostate cancer patients. Oncol Res 18(10):493\u2013501","journal-title":"Oncol Res"},{"issue":"8","key":"365_CR26","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.1600913","volume":"197","author":"PT Nerdal","year":"2016","unstructured":"Nerdal PT, Peters C, Oberg HH, Zlatev H, Lettau M, Quabius ES, Sousa S, Gonnermann D, Auriola S, Olive D, M\u00e4\u00e4tt\u00e4 J, Janssen O, Kabelitz D (2016) Butyrophilin 3A\/CD277-dependent activation of human \u03b3\u03b4 T cells: accessory cell capacity of distinct leukocyte populations. J Immunol 197(8):3059\u20133068","journal-title":"J Immunol"},{"issue":"5","key":"365_CR27","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ijc.30109","volume":"139","author":"S Paul","year":"2016","unstructured":"Paul S, Lal G (2016) Regulatory and effector functions of gamma\u2013delta (\u03b3\u03b4) T cells and their therapeutic potential in adoptive cellular therapy for cancer. Int J Cancer 139(5):976\u2013985","journal-title":"Int J Cancer"},{"issue":"9","key":"365_CR28","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1210\/jc.2010-0597","volume":"95","author":"IR Reid","year":"2010","unstructured":"Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM (2010) Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 95(9):4380\u20134387","journal-title":"J Clin Endocrinol Metab"},{"key":"365_CR29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2008.07435.x","volume":"144","author":"AJ Roelofs","year":"2009","unstructured":"Roelofs AJ, Jauhiainen M, Monkkonen H, Rogers MJ, Monkkonen J, Thompson K (2009) Peripheral blood monocytes are responsible for \u03b3\u03b4 T cell activation induced by zoledronic acid through accumulation of IPP\/DMAPP. Br J Haematol 144:245\u2013250","journal-title":"Br J Haematol"},{"issue":"2","key":"365_CR30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40261-012-0041-1","volume":"33","author":"P Sieber","year":"2013","unstructured":"Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, Meier C (2013) Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice. Clin Drug Investig 33(2):117\u2013122","journal-title":"Clin Drug Investig"},{"issue":"2","key":"365_CR31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.celrep.2013.09.004","volume":"5","author":"E Tonti","year":"2013","unstructured":"Tonti E, Jim\u00e9nez de Oya N, Galliverti G, Moseman EA, Di Lucia P, Amabile A, Sammicheli S, De Giovanni M, Sironi L, Chevrier N, Sitia G, Gennari L, Guidotti LG, von Andrian UH, Iannacone M (2013) Bisphosphonates target b cells to enhance humoral immune responses. Cell Rep 5(2):323\u2013330","journal-title":"Cell Rep"},{"key":"365_CR32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jbmr.1797","volume":"28","author":"JL Welton","year":"2013","unstructured":"Welton JL, Morgan MP, Mart\u00ed S, Stone MD, Moser B, Sewell AK, Turton J, Eberl M (2013) Monocytes and \u03b3\u03b4 T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial. J Bone Miner Res 28:464\u2013471","journal-title":"J Bone Miner Res"},{"key":"365_CR33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.chembiol.2006.08.007","volume":"13","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Song Y, Yin F, Broderick E, Siegel K, Goddard A, Nieves E, Pasa-Tolic L, Tanaka Y, Wang H, Morita CT, Oldfield E (2006) Structural studies of V\u03b32V\u03b42 T cell phosphoantigens. Chem Biol 13:985\u2013992","journal-title":"Chem Biol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-017-0365-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T11:21:51Z","timestamp":1509794511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-017-0365-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,31]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["365"],"URL":"https:\/\/doi.org\/10.1007\/s10787-017-0365-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,31]]}}}